Jennison Associates LLC Blueprint Medicines Corp Transaction History

Jennison Associates LLC

$141 Billion
Q1 2025

A detailed history of Jennison Associates LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Jennison Associates LLC holds 348,817 shares of BPMC stock, worth $44.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

348,817

Previous 360,208 3.16%

Holding current value

$44.7 Million

Previous $31.4 Million 1.73%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	SELL	$86.69 - $115.63 $987,485 - $1.32 Million	-11,391 Reduced 3.16%	348,817 $30.9 Million
Q4 2024 Jan 24, 2025	BUY	$82.48 - $101.39 $29.7 Million - $36.5 Million	360,208 New	360,208 $31.4 Million
Q1 2022 May 11, 2022	SELL	$54.1 - $110.08 $13.6 Million - $27.7 Million	-251,237 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$94.25 - $115.99 $13.7 Million - $16.8 Million	-144,893 Reduced 36.58%	251,237 $26.9 Million
Q3 2021 Nov 09, 2021	SELL	$80.98 - $109.47 $677,883 - $916,373	-8,371 Reduced 2.07%	396,130 $40.7 Million
Q2 2021 Aug 12, 2021	SELL	$82.78 - $101.0 $696,345 - $849,612	-8,412 Reduced 2.04%	404,501 $35.6 Million
Q1 2021 May 11, 2021	BUY	$90.71 - $108.28 $35.5 Million - $42.4 Million	391,572 Added 1834.83%	412,913 $40.1 Million
Q4 2020 Feb 05, 2021	BUY	$92.08 - $124.48 $1.97 Million - $2.66 Million	21,341 New	21,341 $2.39 Million
Q2 2020 Aug 06, 2020	SELL	$57.09 - $79.27 $3.49 Million - $4.84 Million	-61,058 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$48.11 - $82.22 $20,013 - $34,203	416 Added 0.69%	61,058 $3.57 Million
Q4 2019 Feb 07, 2020	SELL	$66.73 - $82.59 $3.16 Million - $3.92 Million	-47,408 Reduced 43.88%	60,642 $4.86 Million
Q3 2019 Nov 08, 2019	SELL	$72.9 - $101.41 $5.81 Million - $8.08 Million	-79,635 Reduced 42.43%	108,050 $7.94 Million
Q2 2019 Aug 06, 2019	SELL	$73.54 - $97.8 $27,430 - $36,479	-373 Reduced 0.2%	187,685 $0
Q1 2019 May 10, 2019	BUY	$48.7 - $86.6 $10,178 - $18,099	209 Added 0.11%	188,058 $15.1 Million
Q4 2018 Feb 06, 2019	SELL	$45.57 - $74.26 $1.58 Million - $2.58 Million	-34,691 Reduced 15.59%	187,849 $10.1 Million
Q3 2018 Nov 08, 2018	BUY	$58.91 - $78.32 $97,672 - $129,854	1,658 Added 0.75%	222,540 $17.4 Million
Q2 2018 Aug 02, 2018	BUY	$60.96 - $101.18 $756,391 - $1.26 Million	12,408 Added 5.95%	220,882 $14 Million
Q1 2018 Apr 20, 2018	BUY	$73.28 - $102.95 $2.08 Million - $2.92 Million	28,389 Added 15.76%	208,474 $19.1 Million
Q4 2017 Jan 25, 2018	SELL	$62.91 - $88.32 $3.05 Million - $4.29 Million	-48,532 Reduced 21.23%	180,085 $13.6 Million
Q3 2017 Nov 03, 2017	BUY	$42.37 - $69.67 $9.69 Million - $15.9 Million	228,617	228,617 $15.9 Million

Others Institutions Holding BPMC

# of Institutions

391

Shares Held

68.5M

Call Options Held

1.54M

Put Options Held

1.08M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Blueprint Medicines Corp Transaction History